Microfluidic Devices for Angiogenesis

Studies in Mechanobiology, Tissue Engineering and Biomaterials

Volumn 12, Issue , 2013, Pages 93-120

  Vickerman, Vernella ^a   Kim, Choong ^a   Kamm, Roger D ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Fluid Shear Stress; Microfluidic Device; Microfluidic System; Multiple Cell Type; Vascular Network

Indexed keywords

EID: 84962770944     PISSN: 18682006     EISSN: 18682014     Source Type: Book Series    
DOI: 10.1007/978-3-642-30856-7_5     Document Type: Chapter

References (139)

1. Li, W.W., et al.: The role of therapeutic angiogenesis in tissue repair and regeneration. Adv. Skin Wound Care. 18, 491–500 (2005)
2. Carmeliet, P.: Angiogenesis in life, disease and medicine. Nature 438(15), 932–936 (2005)
3. Nikol, S.: Angiogenesis and cardiovascular disease: how long will angiogenesis last and how can we stop it. Dialogues Cardiovasc. Med. 6(3), 190–196 (2001)
4. Jain, R.K., et al.: Quantitative angiogenesis assays: progress and problems. Nat. Med. 3(11), 1203–1208 (1997)
5. Ide, A.G., Baker, N.H., Warren, S.L.: Vascularization of the brown pearce rabbit epithelium transplant as seen in the transparent ear chamber. Am. J. Roentgenol. 42, 891–899 (1939)
6. Sandison, J.C.: A new method for the microscopic study of living growing tissues by the introduction of a transparent chamber in the rabbit’s ear. Anat. Rec. 28, 281–287 (1924)
7. Jaffe, E.A., et al.: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Investig. 52, 2745–2756 (1973)
8. Gimbrone, M.A., et al.: Human vascular endothelial cells in culture. Growth and DNA synthesis. J. Cell Biol. 60, 673–684 (1974)
9. Folkman, J., Haudenschild, C.C., Zetter, B.R.: Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 76(10), 5217–5221 (1979)
10. Folkman, J., Haudenschild, C.: Angiogenesis in vitro. Nature 288(11), 551–556 (1980)
11. Yoshida, A., Anand-Apte, B., Zetter, B.R.: Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13(1–2), 57–64 (1996)
12. Seymour, K.A., et al.: Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regulated. Am. J. Surg. 202(5), 553–557 (2011)
13. Thomsen, R., Lade, N.A.: A Boyden chamber-based method for characterization of astrocyte protrusion localized RNA and protein. Glia. 59(11), 1782–1792 (2011)
14. Zabel, B.A., et al.: The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol. Cancer 10, 73 (2011)
15. Lee, W.Y., et al.: In vitro neutrophil transepithelial migration. Methods Mol. Biol. 341, 205–215 (2006)
16. Schleef, R.R., Birdwell, C.R.: The effect of fibrin on endothelial cell migration in vitro. Tissue Cell 14(4), 629–636 (1982)
17. Pratt, D.M., et al.: Mechanisms of cytoskeletal regulation. modulation of aortic endothelial cell spectrin by extracellular matrix. Am. J. Pathol. 117(3), 349–354 (1984)
18. Tapper, D., et al.: Capillary endothelial cell migration: stimulating activity of aqueous humor from patients with ocular cancers. J. Natl. Cancer Inst. 71(3), 501–505 (1983)
19. Dewey Jr, C.F., et al.: The dynamic response of vascular endothelial cells to fluid shear stress. J. Biomech. Eng. 103(3), 177–185 (1981)
20. Levesque, M.J., Nerem, R.M.: The elongation and orientation of cultured endothelial cells in response to shear stress. J. Biomech. Eng. 107(4), 341–347 (1985)
21. Eskin, S.G., et al.: Response of cultured endothelial cells to steady flow. Microvasc. Res. 28(1), 87–94 (1984)
22. Terry, S.C., Jernab, J.H., Angell, J.B.: A gas chromatographic air analyzer fabricated on a silicon wafer. IEEE Trans. Electron Devices 26(12), 1880–1886 (1979)
23. Bassous, E., Taub, H.H., Kuhn, L.: Ink jet printing nozzle arrays etched in silicon. Appl. Phys. Lett. 31, 135–137 (1977)
24. Wilding, P., et al.: Manipulation and flow of biological fluids in straight channels micromachined in silicon. Clin. Chem. 40, 43–47 (1994)
25. Duffy, D.C., et al.: Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal. Chem. 70, 4974–4984 (1998)
26. McDonald, J.C., et al.: Fabrication of microfluidic system in poly(dimethylsiloxane). Electrophoresis 21, 27–40 (2000)
27. Chovan, T., Guttman, A.: Microfabricated devices in biotechnology and biochemical processing. Trends Biotechnol. 20(3), 116–122 (2002)
28. Verpoorte, E.: Microfluidic chips for clinical and forensic analysis. Electrophoresis 23(5), 677–712 (2002)
29. Watts, P., Haswell, S.J.: Microfluidic combinatorial chemistry. Curr. Opin. Chem. Biol. 7(3), 380–387 (2003)
30. Breslauer, D.N., Lee, P.J., Lee, L.P.: Microfluidics-based system biology. Mol. BioSyst. 2(2), 97–112 (2006)
31. Andersson, H., Berg, A.: Microfabrication and microfluidics for tissue engineering: sate of the art and future opportunities. Lab. Chip 4(2), 98–103 (2004)
32. Park, T.H., Shuler, M.L.: Integration of cell culture and microfabrication technology. Biotechnol. Prog. 19(2), 243–253 (2003)
33. Jain, K.K.: Applications of biochips from diagnostics to personalized medicine. Curr. Opin. Drug Discov. Devel. 7(3), 285–289 (2004)
34. Wheeler, M.B., et al.: Application of sexed semen technology to in vitro embryo production in cattle. Theriogenology 65(1), 219–227 (2006)
35. Vickerman, V., et al.: Design, fabrication and implementation of a novel multi-parameter control microfluidic platform for three-dimensional cell culture and real-time imaging. Lab. Chip 8, 1468–1477 (2008)
36. Pardanaud, L., Yassine, F., Dieterlen-Lievre, F.: Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Dev. 105, 473–485 (1989)
37. James, J.M., Jennifer, L.W.: Vascularization of engineered tissues: approaches to promote angiogenesis. Curr. Top. Med. Chem. 7, 300–310 (2008)
38. Fong, G.-H.: Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 11, 121–140 (2008)
39. Rankin, E.B., Giaccia, A.J.: The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15, 678–685 (2008)
40. Bernardini, G., et al.: Analysis of the role of chemokines in angiogenesis. J. Immunol. Methods 273(1–2), 83–101 (2003)
41. Cassavaugh, J., Lounsbury, K.: Hypoxia-mediated biological control. J. Cell. Biochem. 112, 735–744 (2011)
42. Hickey, M.M., Simon, M.C.: Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr. Top. Dev. Biol. 76, 217–257 (2006)
43. Shweiki, D., et al.: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992)
44. Carmeliet,P, et al.: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380(s.l), 435–39 (1996)
45. Ferrara, N., et al.: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439–442 (1996)
46. Park, J.E., et al.: Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol. Cell. Proteomics 9(6), 1085–1099 (2010)
47. Kunz, M., Ibrahim, S.M.: Molecular responses to hypoxia in tumor cells. Mol. Cancer 2(23), (2003)
48. Heinzman, J.M., Browe, S.L., Bush, J.E.: Comparison of angiogenesis-related factor expression in primary tumor cultures under normal and hypoxic growth conditions. Cancer Cell Int. 8, 11 (2008)
49. Fukamara, D., et al.: Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715–725 (1998)
50. Tuxhorn, J.A., et al.: Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res. 62, 3298–3307 (2002)
51. Darland, D.C., D’Amore, P.A.: Blood vessel maturation: vascular development comes of age. J. Clin. Invest. 103(2), 157–158 (1999)
52. Szekanecz, Z., Koch, A. E.: Chemokines and cytokines in inflammatory angiogenesis. [Book Section] Angiogenesis in inflammation; mechanisms and clinical correlates/book auth. Seed Michael P and Walsh David A. [s.l.] Birkhauser Base
53. Kiefer, F., Siekmann, A.F.: The role of chemokines and their receptor in angiogenesis. Cell Mol. Life Sci. 68, 2811–2830 (2011)
54. Seed, M.P., Walsh, D.A.: Angiogenesis in inflamation; mechanisms and clinical correlates. Birkhauser Basel, Germany (2008)
55. Nagy, J.A., et al.: Why are tumour blood vessels abnormal and why is it important to know? Br. J. Cancer 100, 865–869 (2009)
56. Brem, H., Tomic-Canic, M.: Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest. 117, 1219–1222 (2007)
57. Eming, S.A., Krieg, T., Davidson, J.M.: Gene therapy and wound healing. Clin. Dermatol. 25, 79–92 (2007)
58. Takeshita, S., et al.: Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments sollateral vessel formation in a rabbit ischemic hindlimb model. J. Clin. Invest. 93, 662–670 (1994)
59. Cao, R., et al.: Angiogenic synergy, vascular stability and improvement of hind-limb ischemia by a combination PDGF-BB and FGF-2. Nat. Med. 9, 604–613 (2003)
60. Nikol, S., et al.: Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol. Ther. 16, 972–978 (2008)
61. Thackham, J.A., McElwain, D.L., Long, R.J.: The use of hyperbaric oxygen therapy to treat chronic wounds: a review. Wound Repair Regen. 16, 321–330 (2008)
62. Cipolla, J., et al.: Negative pressure wound therapy: unusual and innovative applications. OPUS 12. Scientist 2, 15–29 (2008)
63. Baldwin, C., et al.: Topical negative pressure stimulates endothelial migration and proliferation: a suggested mechanism for improved integration of Integra. Ann. Plast. Surg. 62, 92–96 (2009)
64. Potter, M.J., et al.: In vitro optimization of topical negative pressure regimens for angiogenesis into synthetic dermal replacements. Burns 34, 164–174 (2008)
65. Umit, A., et al.: Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids. J. Clin. Endocrinol. Metab. 62(11), 5794–5802 (2004)
66. Nagel, T., et al.: Shear stresses selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J. Clin. Invest. 94, 885–891 (1994)
67. Davies, P.F., Tripathi, S.C.: Mechanical stress mechanisms and the cell: an endothelial paradigm. Circ. Res. 72, 239–245 (1993)
68. Davies, P.F.: Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat. Rev. Cardiol. 6, 16–26 (2009)
69. Li, Z., Guan, J.: Hydrogels for cardiac tissue engineering. Polymers 3, 740–761 (2011)
70. Even-Ram, S., Yamada, K.M.: Cell migration in 3D matrix. Curr. Opin. Cell Biol. 17, 524–532 (2005)
71. Therriault, D., White, S.R., Lewis, J.A.: Chaotic mixing in three-dimensional microvascular networks fabricated by direct-write assembly. Nat. Mater. 2, 265–271 (2003)
72. Lim, D., et al.: Fabrication of microfluidic mixers and artificial vasculatures using a high-brightness diode-pumped Nd:YAG laser direct write method. Lab. Chip 3, 318–323 (2003)
73. Chen, C.S., Mrksich, M., Huang, S., Whitesides, G.M., Ingber, D.E.: Geometric control of cell life and death. Science 276(30), 1425–1428 (1997)
74. Johnson, M., Liddiard, G., Eddings, M., Gale, B.: Bubble inclusion and removal using PDMS membrane-based gas permeation for applications in pumping, valving and mixing in microfluidic devices. J. Micromech. Microeng. 19, 1–9 (2009)
75. Toepke, M.W., Beebe, D.J.: PDMS absorption of small molecules and consequences in microfluidic applications. Lab. Chip 6, 1484–1486 (2006)
76. Borenstein, J., et al.: Microfabrication technology for vascularized tissue engineering. Biomed. Microdevices 4, 167–175 (2002)
77. Shin, M., et al.: Endothelialized networks with a vascular geometry in microfabricated poly (dimethyl siloxane). Biomed. Microdevices 6, 269–278 (2004)
78. Golden, A.P., Tien, J.: Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial element. Lab. Chip 7, 720–725 (2007)
79. Raghavan, S., Desai, R.A., Kwon, Y., Mrksich, M., Chen, C.S.: Micropatterned dynamically adhesive substrates for cell migration. Langmuir 26, 17733–17738 (2010)
80. Chrobak, K.M., Potter, D.R., Tien, J.: Formation of perfused, functional microvascular tubes in vitro. Microvasc. Res. 71, 185–196 (2006)
81. Price, G.M., et al.: Effect of mechanical factors on the function of engineered humanblood microvessels in microfluidic collagengels. Biomaterials 31, 6182–6189 (2010)
82. Reinhart-King, C.A., Dembo, M., Hammer, D.A.: Endothelial cell traction forces on RGD-derivatized polyacrylamide substrata. Langmuir 19(5), 1573–1579 (2003)
83. Gagnon, E., Cattaruzzi, P., Griffith, M.: Human vascular endothelial cells with extended life spans: in vitro cell response, protein expression, and angiogenesis. Angiogenesis 5, 21–33 (2002)
84. Nicosia, R.F., Tchao, R., Leighton, J.: Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Bes. 43, 2159–2166 (1983)
85. Nakatsu, M.N., Hughes, C.C.: An optimized three-dimensional in vitro model for the analysis of angiogenesis. Methods Enzymol. 443, 65–82 (2008)
86. Conway, E.M., Collen, D., Carmeliet, P.: Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507–521 (2001)
87. Vailhé, B., Vittet, D., Feige, J–.J.: In vitro models of vasculogenesis and angiogenesis. Lab. Invest. 81(4), 439–452 (2001)
88. Barkefors, I., Thorslund, S., Nikolajeff, F., Kreuger, J.: A fluidic device to study directional abgiogenesis in complex tissue and organ culture models. Lab. Chip 9, 529–535 (2009)
89. Carrion, B., et al.: Recreating the perivascular niche ex vivo using a microfluidic approach. Biotechnol. Bioeng. 107(6), 1020–1028 (2010)
90. Chung, S., et al.: Cell migration into scaffolds under co-culture conditions in a microfluidic platform. Lab. Chip 9, 269–275 (2009)
91. Jeong, G.S., et al.: Microfluidic assay of endothelial cell migration in 3D interpenetrating polymer semi-network HA-Collagen hydrogel. Biomed. Microdevices 13(4), 717–723 (2011)
92. Yamamura, N., Sudo, R., Ikeda, M., Tanishita, K.: Effects of the mechanical properties of collagen gel on the in vitro formation of microvessel networks by endothelial cells. Tissue Eng. 13, 1443–1453 (2007)
93. Shin, Y., et al.: In vitro 3D collective sprouting angiogenesis under orchestrated ANG-1 and VEGF gradients. Lab. Chip 11, 2175–2181 (2011)
94. Kang, H., Bayless, K.J., Kaunas, R.: Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices. Am. J. Physiol. Heart Circ. Physiol. 295, H2087– H2097 (2008)
95. Tarbell, J.M.: Shear stress and endothelial transport barrier. J Cardiovasc. Res. 87, 329–330 (2010)
96. Sarin, H., et al.: Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors. J. Transl. Med. 7, 51 (2009)
97. Vera, R.H., et al.: Interstitial fluid flow intensity modulates endothelial sprouting in restricted src-activated cell clusters during capillary morphogenesis. Tissue Eng. Part A 15(1), 175–185 (2009)
98. Song, J.W., Munn, L.L.: Fluid forces control endothelial sprouting. PNAS 108(37), 15342–15347 (2011)
99. DeMaio, L., Tarbell, J.M., Scaduto Jr, R.C., Gardner, T.W., Antonetti, D.A.: A transmural pressure gradient induces mechanical and biological adaptive responses in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 286(2H), 731–741 (2004)
100. Huang, C.P., et al.: Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab. Chip 9, 1740–1748 (2009)
101. Doran, M.R., et al.: A cell migration device that maintains a defined surface with no cellular damage during wound edge generation. Lab. Chip 9, 2364–2369 (2009)
102. Sudo, R., et al.: Transport-mediated angiogenesis in 3D epithelial co culture. FASEB J. 23(37), 2155–2164 (2009)
103. Mack, P.J.: Biomechanical regulation of endothelium-dependent events critical for adaptive remodeling. J. Biol. Chem. 284(13), 8412–8420 (2009)
104. Prabhakar, N.R., Fields, R.D., Baker, T., Fletcher, E.C.: Intermittent hypoxia: cell to system. Am. J. Physiol. Lung Cell Mol. Physiol. 281L, 524–528 (2001)
105. Verbridge, S.S., et al.: Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis. Tissue Eng. A 16, 2133–2141 (2010)
106. Truskey, G.A.: Endothelial cell vascular smooth muscle cell co-culture assay for high throughput screening assays for discovery of anti-angiogenesis agents and other therapeutic molecules. Int. J. High Throughput Screening 1, 171–181 (2010)
107. Griffith, C.K., et al.: Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng. 11, 257–266 (2005)
108. Chen, A.A., Underhill, G.H., Bhatia, S.N.: Multiplexed, high-throughput analysis of 3D microtissue suspensions. Integr. Biol. 2, 517–527 (2010)
109. Seaman, M.E., Peirce, S.M., Kelly, K.: Rapid analysis of vessel elements (RAVE): a tool for studying physiologic, pathologic and tumor angiogenesis. PLoS ONE 6(6), 1–8 (2011)
110. Wood, L.B., Kamm, R.D., Asada, H.H.: A stochastic broadcast feedback approach to regulating cell population morphology for microfluidic angiogenesis platforms. IEEE Trans. Biomed. Eng. 56(9), 2299–2303 (2009)
111. Ferrara, N.: Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25(4), 581–611 (2004)
112. Metheny-Barlow, L.J., Li, L.Y.: The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res. 13(5), 309–317 (2003)
113. Nissen, L.J., et al.: Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest. 117(10), 2766–2777 (2007)
114. Li, A., et al.: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170(6), 3369–3376 (2003)
115. Deshane, J., et al.: Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. JEM 204(3), 605–618 (2007)
116. Ferrari, G., et al.: VEGF, a prosurvival factor, acts in concert with TGF-beta to induce endothelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A 103(46), 17260–17265 (2006)
117. Zhang, Y.W., Su, Y., Volpert, O.V., Vande Woude, G.F.: Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. U.S.A 100(22), 12718–12723 (2003)
118. O’Reilly, M.S., et al.: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell 79(2), 315–328 (1994)
119. O’Reilly, M.S., et al.: Endostatin; an endogenoud inhibitor of angiogenesis and tumor growth. Cell 88(2), 277–285 (1997)
120. Volpert, O.V., et al.: Inhibition of angiogenesis by interleukin 4. J. Exp. Med. 188(6), 1039–1046 (1998)
121. Nishimura, Y., et al.: IL-13 attenuates vascular tube formation via JAK2-STAT6 pathway. Circ. J. 72(3), 469–475 (2008)
122. Bikfalvi, A.: Platelet factor 4: an inhibitor of angiogenesis. Semin. Thromb. Hemost. 30(3), 379–385 (2004)
123. Good, D.J., et al.: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Aca. Sci. U.S.A. 87(17), 6624–6628 (1990)
124. Pike, S.E., et al.: Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J. Exp. Med. 188(12), 2349–2356 (1998)
125. Folkman, J.: Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285(21), 1182–1186 (1971)
126. Sapieha, P., et al.: Proliferative retinopathies: angiogenesis that blinds. Int. J. Biochem. Cell Biol. 42, 5–12 (2010)
127. Di, S.R., Felice, F., Balbarini, A.: Angiogenesis as a risk factor for plaque vulnerability. Curr. Pharm. Des. 15(10), 1095–1106 (2009)
128. Moulton, K.S.: Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr. Opin. Lipidol. 17(5), 548–555 (2006)
129. Virmani, R., et al.: Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler. Thromb. Vasc. Biol. 25, 2054–2061 (2005)
130. Koch, A. E., Distler, O.:Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res. Ther. 9(2), S3 (2007) (doi:10.1186/ar2187)
131. Heidenreich, R., Rocken, M., Ghoreschi, K.: Angiogenesis drives psoriasis pathogenesis. Int. J. Exp. Path. 90, 232–248 (2009)
132. Ribatti, D., et al.: Angiogenesis in asthma. Clin. Exp. Allergy 39, 1815–1821 (2009)
133. Taylor, R.N., et al.: Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci. 16(2), 140–146 (2009)
134. Coulon, S., et al.: Angiogenesis in chronic liver disease and its complications. Liver Int. 31(2), 146–162 (2010)
135. Freedman, S.B., Isner, J.M.: Therapuetic angiogenesis for coronary artery disease. Ann. Intern. Med. 136, 54–71 (2002)
136. Arenillas, J.F., et al.: The role of angiogenesis in damage and recovery from ischemic stroke. Curr. Treat. Options Cardiovasc. Med. 9, 205–212 (2007)
137. Cui, T., Kirsner, R. S., Jie, L, et al..: Angiogenesis in chronic wounds. [Book Section]// Advances in Wound Care. 1/book auth. Sen, C. K., [s.l.], Mary Ann Liebert, Inc., 1 (2010)
138. Vailhé, B., Vittet, D., Feige, J.: In vitro models of vasculogenesis and angiogenesis. Lab. Invest. 81(4), 439–452 (2001)
139. Chung, S., et al.: Surface-treatment-induced three-dimensional capillary morphogenesis in a microfluidic platform. Adv. Mater. 21, 4863–4867 (2009)